149 related articles for article (PubMed ID: 31160688)
1. Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.
Morse N; Jamaspishvili T; Simon D; Patel PG; Ren KYM; Wang J; Oleschuk R; Kaufmann M; Gooding RJ; Berman DM
Lab Invest; 2019 Oct; 99(10):1561-1571. PubMed ID: 31160688
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.
Banerjee S; Zare RN; Tibshirani RJ; Kunder CA; Nolley R; Fan R; Brooks JD; Sonn GA
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3334-3339. PubMed ID: 28292895
[TBL] [Abstract][Full Text] [Related]
4. Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry.
Guenther S; Muirhead LJ; Speller AV; Golf O; Strittmatter N; Ramakrishnan R; Goldin RD; Jones E; Veselkov K; Nicholson J; Darzi A; Takats Z
Cancer Res; 2015 May; 75(9):1828-37. PubMed ID: 25691458
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry.
Kerian KS; Jarmusch AK; Pirro V; Koch MO; Masterson TA; Cheng L; Cooks RG
Analyst; 2015 Feb; 140(4):1090-8. PubMed ID: 25521825
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Metabolic Signature for Cancer Diagnosis Using Desorption Electrospray Ionization Mass Spectrometric Imaging.
Banerjee S; Manna SK
Methods Mol Biol; 2019; 1928():275-297. PubMed ID: 30725461
[TBL] [Abstract][Full Text] [Related]
7. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging.
Bensussan AV; Lin J; Guo C; Katz R; Krishnamurthy S; Cressman E; Eberlin LS
Clin Chem; 2020 Nov; 66(11):1424-1433. PubMed ID: 33141910
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.
Spur EM; Decelle EA; Cheng LL
Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1(0 1):S60-71. PubMed ID: 23549758
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
[TBL] [Abstract][Full Text] [Related]
11. A graphical data processing pipeline for mass spectrometry imaging-based spatially resolved metabolomics on tumor heterogeneity.
Huang L; Mao X; Sun C; Luo Z; Song X; Li X; Zhang R; Lv Y; Chen J; He J; Abliz Z
Anal Chim Acta; 2019 Oct; 1077():183-190. PubMed ID: 31307708
[TBL] [Abstract][Full Text] [Related]
12. Identification of diagnostic metabolic signatures in clear cell renal cell carcinoma using mass spectrometry imaging.
Vijayalakshmi K; Shankar V; Bain RM; Nolley R; Sonn GA; Kao CS; Zhao H; Tibshirani R; Zare RN; Brooks JD
Int J Cancer; 2020 Jul; 147(1):256-265. PubMed ID: 31863456
[TBL] [Abstract][Full Text] [Related]
13. Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer.
Huan T; Troyer DA; Li L
Sci Rep; 2016 Aug; 6():32272. PubMed ID: 27578275
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF).
Wang X; Han J; Hardie DB; Yang J; Pan J; Borchers CH
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):755-767. PubMed ID: 28017863
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
[TBL] [Abstract][Full Text] [Related]
16. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic imaging for human prostate cancer detection.
Wu CL; Jordan KW; Ratai EM; Sheng J; Adkins CB; Defeo EM; Jenkins BG; Ying L; McDougal WS; Cheng LL
Sci Transl Med; 2010 Jan; 2(16):16ra8. PubMed ID: 20371475
[TBL] [Abstract][Full Text] [Related]
18. Aqueous metabolome of tissue-specific conditional Pten-knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma.
Kim S; Li L; Zhang J; Jiang C; Lü J
Prostate; 2022 Jan; 82(1):154-166. PubMed ID: 34662447
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
